Controls nausea and vomiting associated with certain types of anesthesia and surgery. ANDA 87953, held by Pharmobedient. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 87953 (Promethazine Plain), held by Pharmobedient, was first approved by FDA on Nov 15, 1982, with 21 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Promethazine is useful for: Perennial and seasonal allergic rhinitis. Vasomotor rhinitis. Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amelioration of allergic reactions to blood or plasma. Dermographism. Anaphylactic reactions, as adjunctive therapy to epinephrine and other standard measures, after the acute manifestations have been controlled. Preoperative, postoperative, or obstetric sedation. Prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 15, 1982 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Plain6.25MG/5ML · syrup;oral | Promethazine Hydrochloride | RxReference drug |
| Apr 4, 2006 | Supplement 36Labeling | Approved | None posted |
| Dec 21, 2005 | Supplement 35Labeling | Approved | None posted |
| Feb 17, 2000 | Supplement 32Manufacturing | Approved | None posted |
| Feb 17, 2000 | Supplement 31Manufacturing | Approved | None posted |
| Feb 17, 2000 | Supplement 30Manufacturing | Approved | None posted |
| Feb 17, 2000 | Supplement 29Labeling | Approved | None posted |
| Feb 17, 2000 | Supplement 28Manufacturing | Approved | None posted |
| Jun 5, 1995 | Supplement 22Labeling | Approved | None posted |
| Aug 10, 1994 | Supplement 21Labeling | Approved | None posted |
| Feb 11, 1992 | Supplement 20Labeling | Approved | None posted |
| Jan 18, 1991 | Supplement 19Labeling | Approved | None posted |
| Jan 19, 1990 | Supplement 18Labeling | Approved | None posted |
| Mar 15, 1989 | Supplement 17Manufacturing | Approved | None posted |
| Mar 16, 1987 | Supplement 11Manufacturing | Approved | None posted |
| Feb 20, 1985 | Supplement 7Manufacturing | Approved | None posted |
| Feb 20, 1985 | Supplement 6Manufacturing | Approved | None posted |
| Feb 20, 1985 | Supplement 5Manufacturing | Approved | None posted |
| Feb 20, 1985 | Supplement 4Manufacturing | Approved | None posted |
| Feb 20, 1985 | Supplement 3Manufacturing | Approved | None posted |
| Feb 20, 1985 | Supplement 2Manufacturing | Approved | None posted |
| Jan 16, 1985 | Supplement 1Manufacturing | Approved | None posted |
| Nov 15, 1982 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters